Repros Therapeutics reprosrx.com


Public list: BIO 2016 (619) Womens Health Startups (450) Pharma Startups (4732)

Repros Therapeutics, formerly Zonagen, focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.

Repros Therapeutics, formerly Zonagen, focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.

Company (Acquired)

Phone: 281-719-3400

Fax: 281-719-3446

2408 Timberloch Place
Suite B-7
The Woodlands, 77380
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Repros Therapeutics $0M Dec 13, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Repros Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Trans-clomiphene metabolites and uses thereof Aug 03, 2012 May 29, 2018 Patent
Clomiphene synthesis using a single solvent Mar 09, 2015 Mar 13, 2018 Patent
Trans-clomiphene for use in cancer therapy Oct 22, 2013 Jun 27, 2017 Patent
Trans-clomiphene and its analogues as agents that increase bone mineral density Jun 03, 2014 Apr 11, 2017 Patent
Compositions and methods for suppressing endometrial proliferation Apr 11, 2014 Apr 11, 2017 Patent
See all 30 patents